Dr. Josephine Sasu-Tenkoramaa collaboratively with Dr. Jeffrey Fudin The World Health Organization’s (WHO) 3-Step Analgesic Ladder adopted in the 1980’s…
Bupes, and Subs, and Surgery, Oh My
Imagine bringing a patient to surgery on a naloxone (Narcan®) intravenous continuous infusion that you cannot stop for at least…
Taking Opioid Education Seriously
Taking opioid education seriously, doctoral students at the Albany College of Pharmacy & Health Sciences (ACPHS) currently enrolled in the…
Will Codeine be the New Hydrocodone in New York State?
Guest Bloggers: Student Pharmacists Kyle Donovan and Danielle Zanella, under the mentorship of Dr. Jeffrey Fudin. . Guest posts by…
Big Pharma from a Marketing and Health Perspective
After reading some recent articles about pharmaceutical spending on marketing, it sparked an interest because of the connection to public health. Most of us have seen those annoying advertisements on television that are followed by a litany of drug side effects. And many of us are affected by the high cost of pharmaceuticals which sometimes is the reason that patients in need of them are noncompliant.
Pain Management, Meet Public Health
Sarah Fudin is the community manager for the George Washington University’s innovative online Masters in Public Health program. Sarah enjoys…
Morphine Serum Levels – How the Numbers Add Up
Guest Blogger: Cory Villanueva, Pharm.D. Candidate 2013, under the mentorship of Dr. Jeffrey Fudin. . Guest posts by Resident and Intern Pharmacists…
The drugs didn’t do this…he did!
My husband’s death was not due to any drug. It was his irresponsible USE of the drug. With permission from…
Dr. Bob Twillman Critiques FDA Opioid Hearing
Bob Twillman, PhD, FAPM is the Director of Policy and Advocacy for the American Academy of Pain Management. A complete…
Calling Presenters Out! Day 2 of FDA Opioids Hearings
Hearing minutes now posted: http://www.fda.gov/downloads/Drugs/NewsEvents/UCM342713.pdf On day 2 of the FDA Public Hearing, Impact of Approved Drug Labeling on Chronic…